Global Transdermal Patch Market Size was estimated at USD 6793 million in 2021 and is projected to reach USD 8701.22 million by 2028, exhibiting a CAGR of 3.54% during the forecast period.
Global Transdermal Patch Market Overview:
Global Transdermal Patch Market Report 2022 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Transdermal Patch involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Transdermal Patch Market
The Transdermal Patch Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Transdermal Patch Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Transdermal Patch Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Transdermal Patch Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Transdermal Patch market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Transdermal Patch Market Segmentation
Global Transdermal Patch Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Transdermal Patch market has been segmented into:
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
By Application, Transdermal Patch market has been segmented into:
Rx Channel
OTC Channel
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Transdermal Patch market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Transdermal Patch market.
Top Key Players Covered in Transdermal Patch market are:
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Gr? 1/4 nenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy's Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Objective to buy this Report:
1. Transdermal Patch analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Transdermal Patch market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction 1.1 Research Objectives 1.2 Research Methodology 1.3 Research Process 1.4 Scope and Coverage 1.4.1 Market Definition 1.4.2 Key Questions Answered 1.5 Market Segmentation Chapter 2:Executive Summary Chapter 3:Growth Opportunities By Segment 3.1 By Type 3.2 By Application Chapter 4: Market Landscape 4.1 Porter's Five Forces Analysis 4.1.1 Bargaining Power of Supplier 4.1.2 Threat of New Entrants 4.1.3 Threat of Substitutes 4.1.4 Competitive Rivalry 4.1.5 Bargaining Power Among Buyers 4.2 Industry Value Chain Analysis 4.3 Market Dynamics 4.3.1 Drivers 4.3.2 Restraints 4.3.3 Opportunities 4.5.4 Challenges 4.4 Pestle Analysis 4.5 Technological Roadmap 4.6 Regulatory Landscape 4.7 SWOT Analysis 4.8 Price Trend Analysis 4.9 Patent Analysis 4.10 Analysis of the Impact of Covid-19 4.10.1 Impact on the Overall Market 4.10.2 Impact on the Supply Chain 4.10.3 Impact on the Key Manufacturers 4.10.4 Impact on the Pricing Chapter 5: Transdermal Patch Market by Type 5.1 Transdermal Patch Market Overview Snapshot and Growth Engine 5.2 Transdermal Patch Market Overview 5.3 Methyl Salicylate-based Patch 5.3.1 Introduction and Market Overview 5.3.2 Historic and Forecasted Market Size (2016-2028F) 5.3.3 Key Market Trends, Growth Factors and Opportunities 5.3.4 Methyl Salicylate-based Patch: Geographic Segmentation 5.4 Rivastigmine Transdermal Patch 5.4.1 Introduction and Market Overview 5.4.2 Historic and Forecasted Market Size (2016-2028F) 5.4.3 Key Market Trends, Growth Factors and Opportunities 5.4.4 Rivastigmine Transdermal Patch: Geographic Segmentation 5.5 Fentanyl Transdermal Patch 5.5.1 Introduction and Market Overview 5.5.2 Historic and Forecasted Market Size (2016-2028F) 5.5.3 Key Market Trends, Growth Factors and Opportunities 5.5.4 Fentanyl Transdermal Patch: Geographic Segmentation 5.6 Lidocaine Patch 5.6.1 Introduction and Market Overview 5.6.2 Historic and Forecasted Market Size (2016-2028F) 5.6.3 Key Market Trends, Growth Factors and Opportunities 5.6.4 Lidocaine Patch: Geographic Segmentation 5.7 Diclofenac Patch 5.7.1 Introduction and Market Overview 5.7.2 Historic and Forecasted Market Size (2016-2028F) 5.7.3 Key Market Trends, Growth Factors and Opportunities 5.7.4 Diclofenac Patch: Geographic Segmentation 5.8 Nicotine Transdermal Patch 5.8.1 Introduction and Market Overview 5.8.2 Historic and Forecasted Market Size (2016-2028F) 5.8.3 Key Market Trends, Growth Factors and Opportunities 5.8.4 Nicotine Transdermal Patch: Geographic Segmentation 5.9 Others 5.9.1 Introduction and Market Overview 5.9.2 Historic and Forecasted Market Size (2016-2028F) 5.9.3 Key Market Trends, Growth Factors and Opportunities 5.9.4 Others: Geographic Segmentation 5.10 5.10.1 Introduction and Market Overview 5.10.2 Historic and Forecasted Market Size (2016-2028F) 5.10.3 Key Market Trends, Growth Factors and Opportunities 5.10.4 : Geographic Segmentation Chapter 6: Transdermal Patch Market by Application 6.1 Transdermal Patch Market Overview Snapshot and Growth Engine 6.2 Transdermal Patch Market Overview 6.3 Rx Channel 6.3.1 Introduction and Market Overview 6.3.2 Historic and Forecasted Market Size (2016-2028F) 6.3.3 Key Market Trends, Growth Factors and Opportunities 6.3.4 Rx Channel: Geographic Segmentation 6.4 OTC Channel 6.4.1 Introduction and Market Overview 6.4.2 Historic and Forecasted Market Size (2016-2028F) 6.4.3 Key Market Trends, Growth Factors and Opportunities 6.4.4 OTC Channel : Geographic Segmentation Chapter 7: Company Profiles and Competitive Analysis 7.1 Competitive Landscape 7.1.1 Competitive Positioning 7.1.2 Transdermal Patch Sales and Market Share By Players 7.1.3 Industry BCG Matrix 7.1.4 Heat Map Analysis 7.1.5 Transdermal Patch Industry Concentration Ratio (CR5 and HHI) 7.1.6 Top 5 Transdermal Patch Players Market Share 7.1.7 Mergers and Acquisitions 7.1.8 Business Strategies By Top Players 7.2 HISAMITSU PHARMACEUTICAL 7.2.1 Company Overview 7.2.2 Key Executives 7.2.3 Company Snapshot 7.2.4 Operating Business Segments 7.2.5 Product Portfolio 7.2.6 Business Performance 7.2.7 Key Strategic Moves and Recent Developments 7.2.8 SWOT Analysis 7.3 JOHNSON & JOHNSON 7.4 NOVARTIS 7.5 UCB PHARMA 7.6 MYLAN 7.7 TEVA PHARMACEUTICAL 7.8 NITTO DENKO 7.9 GR??NENTHAL 7.10 IBSA GROUP 7.11 GSK 7.12 LUYE PHARMA GROUP 7.13 PFIZER 7.14 CHATTEM 7.15 DR REDDY'S LABORATORIES 7.16 BAYER 7.17 MUNDIPHARMA 7.18 ENDO INTERNATIONAL 7.19 BEIJING TIDE PHARMACEUTICAL 7.20 OTHER MAJOR PLAYERS Chapter 8: Global Transdermal Patch Market Analysis, Insights and Forecast, 2016-2028 8.1 Market Overview 8.2 Historic and Forecasted Market Size By Type 8.2.1 Methyl Salicylate-based Patch 8.2.2 Rivastigmine Transdermal Patch 8.2.3 Fentanyl Transdermal Patch 8.2.4 Lidocaine Patch 8.2.5 Diclofenac Patch 8.2.6 Nicotine Transdermal Patch 8.2.7 Others 8.2.8 8.3 Historic and Forecasted Market Size By Application 8.3.1 Rx Channel 8.3.2 OTC Channel Chapter 9: North America Transdermal Patch Market Analysis, Insights and Forecast, 2016-2028 9.1 Key Market Trends, Growth Factors and Opportunities 9.2 Impact of Covid-19 9.3 Key Players 9.4 Key Market Trends, Growth Factors and Opportunities 9.4 Historic and Forecasted Market Size By Type 9.4.1 Methyl Salicylate-based Patch 9.4.2 Rivastigmine Transdermal Patch 9.4.3 Fentanyl Transdermal Patch 9.4.4 Lidocaine Patch 9.4.5 Diclofenac Patch 9.4.6 Nicotine Transdermal Patch 9.4.7 Others 9.4.8 9.5 Historic and Forecasted Market Size By Application 9.5.1 Rx Channel 9.5.2 OTC Channel 9.6 Historic and Forecast Market Size by Country 9.6.1 U.S. 9.6.2 Canada 9.6.3 Mexico Chapter 10: Europe Transdermal Patch Market Analysis, Insights and Forecast, 2016-2028 10.1 Key Market Trends, Growth Factors and Opportunities 10.2 Impact of Covid-19 10.3 Key Players 10.4 Key Market Trends, Growth Factors and Opportunities 10.4 Historic and Forecasted Market Size By Type 10.4.1 Methyl Salicylate-based Patch 10.4.2 Rivastigmine Transdermal Patch 10.4.3 Fentanyl Transdermal Patch 10.4.4 Lidocaine Patch 10.4.5 Diclofenac Patch 10.4.6 Nicotine Transdermal Patch 10.4.7 Others 10.4.8 10.5 Historic and Forecasted Market Size By Application 10.5.1 Rx Channel 10.5.2 OTC Channel 10.6 Historic and Forecast Market Size by Country 10.6.1 Germany 10.6.2 U.K. 10.6.3 France 10.6.4 Italy 10.6.5 Russia 10.6.6 Spain 10.6.7 Rest of Europe Chapter 11: Asia-Pacific Transdermal Patch Market Analysis, Insights and Forecast, 2016-2028 11.1 Key Market Trends, Growth Factors and Opportunities 11.2 Impact of Covid-19 11.3 Key Players 11.4 Key Market Trends, Growth Factors and Opportunities 11.4 Historic and Forecasted Market Size By Type 11.4.1 Methyl Salicylate-based Patch 11.4.2 Rivastigmine Transdermal Patch 11.4.3 Fentanyl Transdermal Patch 11.4.4 Lidocaine Patch 11.4.5 Diclofenac Patch 11.4.6 Nicotine Transdermal Patch 11.4.7 Others 11.4.8 11.5 Historic and Forecasted Market Size By Application 11.5.1 Rx Channel 11.5.2 OTC Channel 11.6 Historic and Forecast Market Size by Country 11.6.1 China 11.6.2 India 11.6.3 Japan 11.6.4 Singapore 11.6.5 Australia 11.6.6 New Zealand 11.6.7 Rest of APAC Chapter 12: Middle East & Africa Transdermal Patch Market Analysis, Insights and Forecast, 2016-2028 12.1 Key Market Trends, Growth Factors and Opportunities 12.2 Impact of Covid-19 12.3 Key Players 12.4 Key Market Trends, Growth Factors and Opportunities 12.4 Historic and Forecasted Market Size By Type 12.4.1 Methyl Salicylate-based Patch 12.4.2 Rivastigmine Transdermal Patch 12.4.3 Fentanyl Transdermal Patch 12.4.4 Lidocaine Patch 12.4.5 Diclofenac Patch 12.4.6 Nicotine Transdermal Patch 12.4.7 Others 12.4.8 12.5 Historic and Forecasted Market Size By Application 12.5.1 Rx Channel 12.5.2 OTC Channel 12.6 Historic and Forecast Market Size by Country 12.6.1 Turkey 12.6.2 Saudi Arabia 12.6.3 Iran 12.6.4 UAE 12.6.5 Africa 12.6.6 Rest of MEA Chapter 13: South America Transdermal Patch Market Analysis, Insights and Forecast, 2016-2028 13.1 Key Market Trends, Growth Factors and Opportunities 13.2 Impact of Covid-19 13.3 Key Players 13.4 Key Market Trends, Growth Factors and Opportunities 13.4 Historic and Forecasted Market Size By Type 13.4.1 Methyl Salicylate-based Patch 13.4.2 Rivastigmine Transdermal Patch 13.4.3 Fentanyl Transdermal Patch 13.4.4 Lidocaine Patch 13.4.5 Diclofenac Patch 13.4.6 Nicotine Transdermal Patch 13.4.7 Others 13.4.8 13.5 Historic and Forecasted Market Size By Application 13.5.1 Rx Channel 13.5.2 OTC Channel 13.6 Historic and Forecast Market Size by Country 13.6.1 Brazil 13.6.2 Argentina 13.6.3 Rest of SA Chapter 14 Investment Analysis Chapter 15 Analyst Viewpoint and Conclusion:
Publisher: Introspective Market Research
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support